Literature DB >> 18261852

Voluntary oral nicotine intake in mice down-regulates GluR2 but does not modulate depression-like behaviors.

Patricia Vieyra-Reyes1, Marina R Picciotto, Yann S Mineur.   

Abstract

Repeated exposure to nicotine induces adaptive changes in the central nervous system including the mesolimbic dopamine (DA) projections from the ventral tegmental area (VTA) to the nucleus accumbens (NAc). These modifications can modulate nicotine reward and reinforcement, but also anxiety and depression-related behaviors. The development of addiction-related phenotypes is known to be modulated by regulation of glutamate receptors, as well as activation of transcription factors including cAMP response element-binding protein (CREB), in the NAc. We investigated the effects of nicotine pre-exposure on nicotine preference and levels of GluR1/2 and CREB in the mesolimbic system in male mice C57BL/6J and BALB/c inbred mice. We also evaluated locomotor activity, anxiety-like and depression-like behaviors known to be affected by nicotine. There were few behavioral changes in mice subjected to chronic nicotine exposure, but there was a marked regulation of GluR2 in the mesolimbic system. Both treated and non-treated animals showed a significant preference for nicotine when facing a choice with a control solution. These results suggest that voluntary nicotine drinking induces nicotine preference in mice, but does not alter a number of affective behaviors. In addition, alterations in CREB and GluR1 levels are not sufficient to explain preference for nicotine in a 2-bottle choice paradigm.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18261852      PMCID: PMC2757003          DOI: 10.1016/j.neulet.2008.01.021

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  28 in total

Review 1.  Addiction, dopamine, and the molecular mechanisms of memory.

Authors:  J D Berke; S E Hyman
Journal:  Neuron       Date:  2000-03       Impact factor: 17.173

Review 2.  Molecular neurobiology of addiction.

Authors:  E J Nestler
Journal:  Am J Addict       Date:  2001

Review 3.  Cellular mechanisms of striatum-dependent behavioral plasticity and drug addiction.

Authors:  S Fasano; R Brambilla
Journal:  Curr Mol Med       Date:  2002-11       Impact factor: 2.222

Review 4.  Synaptic plasticity in drug reward circuitry.

Authors:  Danny G Winder; Regula E Egli; Nicole L Schramm; Robert T Matthews
Journal:  Curr Mol Med       Date:  2002-11       Impact factor: 2.222

5.  CREB activity in the nucleus accumbens shell controls gating of behavioral responses to emotional stimuli.

Authors:  Michel Barrot; Jocelien D A Olivier; Linda I Perrotti; Ralph J DiLeone; Olivier Berton; Amelia J Eisch; Soren Impey; Daniel R Storm; Rachael L Neve; Jerry C Yin; Venetia Zachariou; Eric J Nestler
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-06       Impact factor: 11.205

6.  Common molecular and cellular substrates of addiction and memory.

Authors:  Eric J Nestler
Journal:  Neurobiol Learn Mem       Date:  2002-11       Impact factor: 2.877

7.  Functional implications of decreases in neurogenesis following chronic mild stress in mice.

Authors:  Y S Mineur; C Belzung; W E Crusio
Journal:  Neuroscience       Date:  2007-09-26       Impact factor: 3.590

8.  Peculiar vulnerability to nicotine oral self-administration in mice during early adolescence.

Authors:  Walter Adriani; Simone Macrì; Roberta Pacifici; Giovanni Laviola
Journal:  Neuropsychopharmacology       Date:  2002-08       Impact factor: 7.853

9.  Extinction-induced upregulation in AMPA receptors reduces cocaine-seeking behaviour.

Authors:  Michael A Sutton; Eric F Schmidt; Kwang-Ho Choi; Christina A Schad; Kim Whisler; Diana Simmons; David A Karanian; Lisa M Monteggia; Rachael L Neve; David W Self
Journal:  Nature       Date:  2003-01-02       Impact factor: 49.962

10.  Restricted daily access to water and voluntary nicotine oral consumption in mice: methodological issues and individual differences.

Authors:  Walter Adriani; Simone Macrì; Roberta Pacifici; Giovanni Laviola
Journal:  Behav Brain Res       Date:  2002-08-21       Impact factor: 3.332

View more
  12 in total

Review 1.  Cellular events in nicotine addiction.

Authors:  Rachel E Penton; Robin A J Lester
Journal:  Semin Cell Dev Biol       Date:  2009-01-20       Impact factor: 7.727

2.  Nicotinic partial agonists varenicline and sazetidine-A have differential effects on affective behavior.

Authors:  Jill R Turner; Laura M Castellano; Julie A Blendy
Journal:  J Pharmacol Exp Ther       Date:  2010-04-30       Impact factor: 4.030

3.  Protein kinase C epsilon modulates nicotine consumption and dopamine reward signals in the nucleus accumbens.

Authors:  Anna M Lee; Robert O Messing
Journal:  Proc Natl Acad Sci U S A       Date:  2011-09-12       Impact factor: 11.205

4.  Effects of blockade of α4β2 and α7 nicotinic acetylcholine receptors on cue-induced reinstatement of nicotine-seeking behaviour in rats.

Authors:  Xiu Liu
Journal:  Int J Neuropsychopharmacol       Date:  2013-08-19       Impact factor: 5.176

5.  Menthol disrupts nicotine's psychostimulant properties in an age and sex-dependent manner in C57BL/6J mice.

Authors:  Benjamin W Fait; David C Thompson; Tenna N Mose; Peter Jatlow; Sven E Jordt; Marina R Picciotto; Yann S Mineur
Journal:  Behav Brain Res       Date:  2017-07-22       Impact factor: 3.332

Review 6.  Nicotine: alcohol reward interactions.

Authors:  A Lajtha; H Sershen
Journal:  Neurochem Res       Date:  2010-05-25       Impact factor: 3.996

7.  Positive allosteric modulation of α4β2 nicotinic acetylcholine receptors as a new approach to smoking reduction: evidence from a rat model of nicotine self-administration.

Authors:  Xiu Liu
Journal:  Psychopharmacology (Berl)       Date:  2013-05-28       Impact factor: 4.530

Review 8.  Molecules and circuits involved in nicotine addiction: The many faces of smoking.

Authors:  Marina R Picciotto; Yann S Mineur
Journal:  Neuropharmacology       Date:  2013-04-28       Impact factor: 5.250

9.  The potent and selective α4β2*/α6*-nicotinic acetylcholine receptor partial agonist 2-[5-[5-((S)Azetidin-2-ylmethoxy)-3-pyridinyl]-3-isoxazolyl]ethanol demonstrates antidepressive-like behavior in animal models and a favorable ADME-tox profile.

Authors:  Li-Fang Yu; J Brek Eaton; Han-Kun Zhang; Emily Sabath; Taleen Hanania; Guan-Nan Li; Richard B van Breemen; Paul Whiteaker; Qiang Liu; Jie Wu; Yong-Chang Chang; Ronald J Lukas; Dani Brunner; Alan P Kozikowski
Journal:  Pharmacol Res Perspect       Date:  2014-03-12

10.  miR-181a is a negative regulator of GRIA2 in methamphetamine-use disorder.

Authors:  Kai Zhang; Qingzhong Wang; Xuxiu Jing; Yan Zhao; Haifeng Jiang; Jiang Du; Shunying Yu; Min Zhao
Journal:  Sci Rep       Date:  2016-10-21       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.